NCT04040621 - Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

April 9, 2021

Study Completion Date

May 7, 2021

Conditions

Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia

Interventions

DRUG

Ceftazidime-avibactam

Single intravenous infusion of ceftazidime-avibactam over 2 hours. Dosage will vary depending upon age, weight and renal function.

Trial Locations (4)

Taipei Municipal Wanfang Hospital, Taipei

Chang Gung Memorial Hospital-Linkou, Taoyuan

Wuxi Children's Hospital, Wuxi

Chengdu Women's and Children's Central Hospital, Chengdu